Arcadia Biosciences (NASDAQ:RKDA) Earns Sell Rating from Analysts at StockNews.com

by · The Cerbat Gem

StockNews.com assumed coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Free Report) in a research note released on Friday. The firm issued a sell rating on the basic materials company’s stock.

Arcadia Biosciences Stock Up 7.8 %

Shares of NASDAQ:RKDA opened at $5.00 on Friday. The company has a market cap of $6.83 million, a P/E ratio of -1.17 and a beta of 0.90. The business has a fifty day simple moving average of $4.70 and a 200-day simple moving average of $3.61. Arcadia Biosciences has a 52 week low of $1.85 and a 52 week high of $10.31.

About Arcadia Biosciences

(Get Free Report)

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.

Recommended Stories